Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum
ranging from simple steatosis to non-alcoholic steatohepatitis (NASH): NAFLD causes an …

Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver disorder in the
developed world affecting up to a third of individuals. It is closely associated with features of …

Nonalcoholic fatty liver disease (NAFLD) encompasses a histological spectrum ranging from
simple steatosis to nonalcoholic steatohepatitis (NASH). NAFLD carries a higher risk of …

Calorie-enriched diet and lack of exercise are causing a worldwide surge of obesity, insulin
resistance and lipid accretion in liver (ie hepatic steatosis), which can lead to steatohepatitis …

NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver
condition in the Western world. It is associated with insulin resistance and frequently occurs …

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the
Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic …

In uncontrolled clinical studies, ursodeoxycholic acid (UDCA) had a beneficial effect on
nonalcoholic steatohepatitis (NASH). However, a large controlled trial using UDCA (13‐15 …

Non-alcoholic fatty liver disease (NAFLD) is now the most common liver disease affecting
high proportion of the population worldwide. NAFLD encompasses a large spectrum of …

Non-alcoholic fatty liver disease (NAFLD) is common and may progress to cirrhosis and its
complications. The pathogenesis of steatosis and cellular injury is thought to be related …

Non‐alcoholic fatty liver disease is a new clinicopathological condition of emerging
importance, now recognized as the most common cause of abnormal liver tests. It is …